Advances in Stroke 2017. [Review] 

 -  2018 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>0039-2499 
<br/><br/><label>Standard No.: </label>10.1161/STROKEAHA.118.021380 [doi] STROKEAHA.118.021380 [pii] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>*Anticoagulants/ae [Adverse Effects]<br/>*Antidotes/tu [Therapeutic Use]<br/>*Intracranial Hemorrhages/ci [Chemically Induced]<br/>*Stroke Rehabilitation<br/>*Stroke/th [Therapy]<br/>Antibodies, Monoclonal, Humanized/tu [Therapeutic Use]<br/>Antihypertensive Agents/tu [Therapeutic Use]<br/>Arginine/aa [Analogs & Derivatives]<br/>Arginine/tu [Therapeutic Use]<br/>Delivery of Health Care<br/>Factor Xa/tu [Therapeutic Use]<br/>Health Policy<br/>Humans<br/>Hypertension/dt [Drug Therapy]<br/>Outcome Assessment (Health Care)<br/>Piperazines/tu [Therapeutic Use]<br/>Recombinant Proteins/tu [Therapeutic Use]<br/>Stroke/dg [Diagnostic Imaging]<br/>Stroke/ge [Genetics]<br/>Stroke/pc [Prevention & Control]<br/>Thrombectomy<br/>Thrombolytic Therapy
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar National Rehabilitation Network
<br/><br/><label>Index Terms--Function: </label><br/>Journal Article<br/>Review